These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8147263)

  • 1. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
    Boudíková-Girard B; Scott MC; Weinshilboum R
    Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variation.
    Scott MC; Guerciolini R; Szumlanski C; Weinshilboum RM
    Agents Actions; 1991 Mar; 32(3-4):194-202. PubMed ID: 1907425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human erythrocyte histamine N-methyltransferase: radiochemical microassay and biochemical properties.
    Van Loon JA; Pazmiño PA; Weinshilboum RM
    Clin Chim Acta; 1985 Jul; 149(2-3):237-51. PubMed ID: 4028443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury.
    Costiniti V; Spera I; Menabò R; Palmieri EM; Menga A; Scarcia P; Porcelli V; Gissi R; Castegna A; Canton M
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3050-3059. PubMed ID: 29953926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of the active site of brain monoamine oxidase.
    Youdim MB
    Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
    Girard B; Otterness DM; Wood TC; Honchel R; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1994 Mar; 45(3):461-8. PubMed ID: 8145732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants.
    Futo J; Kupferberg JP; Moss J
    Biochem Pharmacol; 1990 Feb; 39(3):415-20. PubMed ID: 1968337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
    Murphy DL; Karoum F; Pickar D; Cohen RM; Lipper S; Mellow AM; Tariot PN; Sunderland T
    J Neural Transm Suppl; 1998; 52():39-48. PubMed ID: 9564606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts.
    Yu PH; Davis BA
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.